University of Lucknow

TDC Group Promotes Medical Professional Liability Leaders

Retrieved on: 
Friday, June 17, 2022
Solution, Florida Board of Governors, Industry, Association, Innovation and Entrepreneurship Group, The Doctors Company, FACP, Board of directors, MPL, MBA, Insurance, CEO, Centre for Study of Insurance Operations, Physician, MD, University, University of Lucknow, TDC A/S, Stanford University, Risk management, Board, Multimedia, White, TDC, Digital transformation, Organization, Actuarial science, Medicine, Michigan State University, Management, Innovation, Technology

NAPA, Calif., June 17, 2022 /PRNewswire/ --TDC Group has promoted Robert E. White Jr. from his role as Chief Operating Officer of the company's medical professional liability (MPL) subsidiary to President of TDC Group.

Key Points: 
  • NAPA, Calif., June 17, 2022 /PRNewswire/ --TDC Group has promoted Robert E. White Jr. from his role as Chief Operating Officer of the company's medical professional liability (MPL) subsidiary to President of TDC Group.
  • In his new role, Mr. White will oversee all four subsidiaries that make up TDC Group: The Doctors Company, Healthcare Risk Advisors, TDC Specialty Underwriters, and Medical Advantage.
  • He has helped us navigate the pandemic and maximize the potential of our subsidiary business units, both individually and for TDC Group," said Richard E. Anderson, MD, FACP, Chairman and CEO of The Doctors Company and TDC Group.
  • The TDC Group of companies (TDC Group) is the nation's largest physician-owned provider of insurance, risk management, and healthcare practice improvement solutions.

atbtherapeutics Expands Leadership Team and Scientific Advisory Board with Pharmaceutical Industry Experts

Retrieved on: 
Tuesday, October 5, 2021
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, MSD, People, Publication, Medication, Biotechnology, DABT, CSO, Bone, SAB, Case Western Reserve University, Philippe, Business economics, P. R. Mallory and Co Inc, Therapy, Economics, Veteran, Head, Baxter, UCB, Cancer, United States Air Force Scientific Advisory Board, CBO, American Board of Commissioners for Foreign Missions, Board, Marketing, CEO, Merck, University, Antibody, Operation, Stanford University, ATB, AstraZeneca, Dixit, Johnson & Johnson, Neurology, ADC, MBA, MedImmune, Safety, Pharma, Doctor of Philosophy, University of Lucknow, Pharmaceutical industry, Management

atbtherapeutics today announced the appointments of Philippe Vandeput as Chief Business Officer (CBO) and Rakesh Dixit, PhD, as a member of its Scientific Advisory Board (SAB).

Key Points: 
  • atbtherapeutics today announced the appointments of Philippe Vandeput as Chief Business Officer (CBO) and Rakesh Dixit, PhD, as a member of its Scientific Advisory Board (SAB).
  • Their expertise and active engagement in the biopharmaceutical industry will be an important resource for the company as it advances its drug candidates into the clinic.
  • I look forward to working with the leadership team and forging partnerships across the industry.
  • I am eager to work with the other members of the Scientific Advisory Board to define the most effective path to advance atbtherapeutics novel assets.